| scholarly article | Q13442814 |
| P356 | DOI | 10.1158/0008-5472.CAN-10-0874 |
| P8608 | Fatcat ID | release_uzqzghnkuzelnnqfxpnqy4hx5m |
| P698 | PubMed publication ID | 21169411 |
| P50 | author | Greg N. Brooke | Q55965598 |
| Charlotte Bevan | Q71575167 | ||
| P2093 | author name string | Marjorie M Walker | |
| Robin Wait | |||
| David J Mann | |||
| Craig N Robson | |||
| Luke Gaughan | |||
| Sue M Powell | |||
| D Alwyn Dart | |||
| Jonathan Waxman | |||
| Bradley Spencer-Dene | |||
| Simon C Gamble | |||
| Stuart R McCracken | |||
| Rachel L Culley | |||
| P2860 | cites work | Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma | Q24309359 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | prostate cancer | Q181257 |
| P304 | page(s) | 914-924 | |
| P577 | publication date | 2010-12-17 | |
| P1433 | published in | Cancer Research | Q326097 |
| P1476 | title | FUS/TLS is a novel mediator of androgen-dependent cell-cycle progression and prostate cancer growth | |
| P478 | volume | 71 |
| Q26740628 | Advances in genetics: widening our understanding of prostate cancer |
| Q42632659 | Analysis of apoptosis methods recently used in Cancer Research and Cell Death & Disease publications. |
| Q37322621 | Androgen receptor (AR) positive vs negative roles in prostate cancer cell deaths including apoptosis, anoikis, entosis, necrosis and autophagic cell death |
| Q38326097 | Androgen-regulated processing of the oncomir miR-27a, which targets Prohibitin in prostate cancer. |
| Q38908290 | Antiandrogens act as selective androgen receptor modulators at the proteome level in prostate cancer cells. |
| Q88764270 | Arginine methylation of translocated in liposarcoma (TLS) inhibits its binding to long noncoding RNA, abrogating TLS-mediated repression of CBP/p300 activity |
| Q27022532 | Cell-context dependent TCF/LEF expression and function: alternative tales of repression, de-repression and activation potentials |
| Q90196975 | Circular RNA CircFndc3b modulates cardiac repair after myocardial infarction via FUS/VEGF-A axis |
| Q39012681 | Engineered repressors are potent inhibitors of androgen receptor activity. |
| Q24337704 | FUS/TLS is a co-activator of androgen receptor in prostate cancer cells |
| Q34305789 | Functions of FUS/TLS from DNA repair to stress response: implications for ALS. |
| Q31104690 | Gene expression responses to FUS, EWS, and TAF15 reduction and stress granule sequestration analyses identifies FET-protein non-redundant functions |
| Q40576605 | IDH1 mutation-associated long non-coding RNA expression profile changes in glioma |
| Q89966248 | Identification of Specific Long Non-Coding Ribonucleic Acid Signatures and Regulatory Networks in Prostate Cancer in Fine-Needle Aspiration Biopsies |
| Q40786472 | Identification, by systematic RNA sequencing, of novel candidate biomarkers and therapeutic targets in human soft tissue tumors |
| Q37718358 | LncRNA profile study reveals four-lncRNA signature associated with the prognosis of patients with anaplastic gliomas |
| Q57026957 | Long noncoding RNA Meg3 regulates cardiomyocyte apoptosis in myocardial infarction |
| Q33607527 | Long noncoding RNA SchLAH suppresses metastasis of hepatocellular carcinoma through interacting with fused in sarcoma |
| Q36738654 | MicroRNA-141 and its associated gene FUS modulate proliferation, migration and cisplatin chemosensitivity in neuroblastoma cell lines |
| Q47342302 | Mitochondrial abnormalities and disruption of the neuromuscular junction precede the clinical phenotype and motor neuron loss in hFUSWT transgenic mice |
| Q30532680 | Overexpression of human wild-type FUS causes progressive motor neuron degeneration in an age- and dose-dependent fashion |
| Q61811636 | RNA Dysregulation in Amyotrophic Lateral Sclerosis |
| Q38251313 | RNA-binding proteins as molecular links between cancer and neurodegeneration. |
| Q99711125 | Research progress on long non-coding RNAs and their roles as potential biomarkers for diagnosis and prognosis in pancreatic cancer |
| Q90411671 | Synthesis and in-vitro Evaluation of S-allyl Cysteine Ester - Caffeic Acid Amide Hybrids as Potential Anticancer Agents |
| Q35876533 | The co-chaperone p23 promotes prostate cancer motility and metastasis |
Search more.